Cargando…
Radioactive iodine therapy may not improve disease‐specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score‐matched analysis
BACKGROUND: Whether radioactive iodine (RAI) therapy is effective in improving disease‐specific survival (DSS) in patients with follicular variant papillary thyroid cancer (FVPTC) without distant metastasis remains unclear. METHODS: Patients with FVPTC were identified from the Surveillance, Epidemio...
Autores principales: | Wang, Xiaofei, Zheng, Xun, Zhu, Jingqiang, Li, Zhihui, Wei, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248087/ https://www.ncbi.nlm.nih.gov/pubmed/33559196 http://dx.doi.org/10.1002/hed.26637 |
Ejemplares similares
-
The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020) -
The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018) -
Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score–matched analysis
por: Guo, Honghao, et al.
Publicado: (2023) -
Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer
por: Mohapatra, Tushar, et al.
Publicado: (2012) -
Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)